Volume 7, Issue 1

  • 2020, July

    mini review

    The Time is Now for Disruptive Innovation in Pre-Exposure Prophylaxis Adherence MonitoringOpen Access

    PDF358.80 KB 358.80 KB
    Full-Text (HTML)
    Abstract [+]

    Monitoring adherence to pre-exposure prophylaxis is a critical component of reaching ending the human immunodeficiency virus infection (HIV) epidemic goals in the US. Currently, providers still depend on “self-report” pre-exposure prophylaxis (PrEP) adherence, whereby providers ask their patients about their recent pill taking habits. There appears to be growing consensus across the HIV prevention community that “self-report” is an inadequate method of identifying that is in-need of additional adherence support services. In a recent survey, 97% of providers report utilizing self-reported adherence because it is convenient, but only 10% of these providers believe it is accurate. While “self-report” is convenient, evidence and testimonials from diverse stakeholders across the HIV prevention landscape indicate that there is a desire for more accurate, effective adherence monitoring methods. In this mini-review, we will briefly synthesize the emerging evidence and propose a solution to ensure all patients receive the support needed to protect them from HIV acquisition.
    Keywords
    Pre-exposure prophylaxis; HIV; Adherence; Prevention; Self-report.


  • 2020, November

    systematic review

    Revision of Maryland Minor Consent Law on Human Immunodeficiency Virus Infection Prevention: An Outcome of AdvocacyOpen Access

    PDF438.06 KB 438.06 KB
    Full-Text (HTML)
    Abstract [+]

    Objectives
    To date, only few United States (US) states have explicit regulations that allow minors to independently give consent for human immunodeficiency virus infection (HIV) prevention treatments. This manuscript will reflect upon key advocacy efforts leading to the revision of the Maryland Minor Consent Law, evaluate current human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) prevention laws for minors in U.S. states, and highlight resources for health advocacy.
    Methods
    Between 2018-2019, public health professionals in Baltimore, Maryland reviewed the Maryland Minor Consent Law and other adolescent consent laws within the U.S. The professionals advocated for a legal review of the gap by the State Senate and the Office of Attorney General.
    Results
    In May 2019, the public health advocates were successful in their effort for a revision of the Maryland Minor Consent Law to include Treatment for the Prevention of HIV-Consent by minors. Upon their review of all adolescent consent laws within the U.S., they found that only eleven states currently have explicit language indicative of an adolescent’s ability to give consent for pre-exposure prophylaxis (PrEP).
    Conclusion
    This inquiry can change upstream factors such as laws, regulations, policies and institutional practices.
    Keywords
    HIV, Prevention, Pre-exposure prophylaxis, Adolescents, Minor consent law.